Understanding HOCl Technology: The Science Behind Spray8 Advanced Wound Care

Hypochlorous acid — better known as HOCl — has quietly become one of the most interesting molecules in modern topical care. It is not a synthetic invention. It is something your own immune system manufactures every single day to fight off bacteria, fungi and viruses. What recent technology, like that used in Spray8 wound care, has managed to do is stabilise this compound outside the body so it can be delivered directly to damaged tissue or compromised epithelium in a reliable, consistent form.

This article breaks down what HOCl actually is, how it kills pathogens at a biomolecular level, what the peer-reviewed literature says about its safety profile, and why it matters for wound management and nasal microbiome health. The tone is technical, but no medical background is assumed — just curiosity and a willingness to follow the science.

What Exactly Is Hypochlorous Acid (HOCl)?

Chemically, HOCl is a weak acid with the formula HOCl. It exists in equilibrium with its conjugate base, the hypochlorite ion (OCl-), and the ratio between the two is almost entirely dictated by pH. At a pH around 5.0 to 6.5, HOCl is the dominant species — and that matters because HOCl is roughly 80 to 100 times more microbicidally active than OCl- (PMID: 17492050, Wang et al., J Burns Wounds 2007).

In plain language: the same total amount of “chlorine” in solution can be dramatically more effective or dramatically less effective depending on how the formulation is pH-balanced. That is one of the reasons why not all HOCl products are equivalent — and why the stabilisation technology behind a product matters as much as the active ingredient itself.

HOCl is classified as a reactive oxygen species (ROS). It is naturally produced by neutrophils — the most abundant type of white blood cell in human blood — during what immunologists call the respiratory burst. This is the rapid release of oxidants that occurs when a neutrophil engulfs a pathogen into a membrane-bound compartment called a phagosome.

The Neutrophil Connection: How Your Body Makes HOCl

The Myeloperoxidase-H2O2-Chloride System

The specific biochemical pathway that generates HOCl inside neutrophils is one of the best-characterised antimicrobial systems in human biology. It proceeds in three steps:

1. NADPH oxidase activation. When a neutrophil detects a pathogen, it assembles an enzyme complex called NADPH oxidase on the phagosomal membrane. This enzyme transfers electrons from cytosolic NADPH to molecular oxygen (O2), producing superoxide anion (O2-) at rates estimated at several millimolar per second (PMID: 9787133, Hampton et al., Blood 1998).
2. Superoxide dismutation. Superoxide dismutase (SOD) rapidly converts O2- into hydrogen peroxide (H2O2). This step is spontaneous enough that it does not strictly require enzymatic catalysis, but SOD accelerates it by several orders of magnitude.
3. Myeloperoxidase (MPO) catalysis. MPO — a heme-containing enzyme stored in azurophilic granules that fuse with the phagosome — uses H2O2 to oxidise chloride ions (Cl-) into HOCl. The reaction is: H2O2 + Cl- + H+ yields HOCl + H2O. MPO is present at millimolar concentrations inside the phagosome, making this reaction extremely efficient (PMID: 17492050).

The result is a phagosome flooded with HOCl at concentrations estimated to reach 5–25 mM — enough to kill most bacteria within seconds. This is not a gentle process. It is oxidative warfare at the cellular scale.

Why HOCl Is the Primary MPO Product

MPO can also oxidise other halides and pseudohalides. Thiocyanate (SCN-), for example, is oxidised to hypothiocyanous acid (HOSCN). However, chloride is present at roughly 100 mM in plasma — far outcompeting thiocyanate at its typical concentration of 20–100 uM. The kinetic preference of MPO for chloride, combined with chloride’s overwhelming abundance, means that HOCl is the dominant oxidant produced in the neutrophil phagosome (PMID: 35251376).

Modelling the Phagosome: What the Numbers Tell Us

A landmark kinetic model by Winterbourn, Hampton and colleagues (J Biol Chem 2006) simulated the reaction dynamics inside a neutrophil phagosome. Their findings were illuminating: most of the HOCl produced reacts with released granule proteins before it ever reaches the bacterial cell wall. The resulting chloramines — organic compounds where chlorine is bound to nitrogen — may themselves be significant antimicrobial effectors, acting as longer-lived, slower-release reservoirs of oxidative capacity. This has implications for how we think about exogenous HOCl application: the molecule does not need to hit a pathogen directly to be effective. Secondary oxidant species contribute meaningfully to the overall antimicrobial environment.

Mechanism of Action: How HOCl Kills Pathogens

HOCl’s antimicrobial mechanism is fundamentally different from that of antibiotics. It does not target a single enzyme or metabolic pathway. Instead, it acts as a broad-spectrum oxidant that damages multiple classes of biomolecules simultaneously. This is precisely why resistance development has never been documented — a pathogen cannot easily evolve defences against having its proteins, lipids and DNA oxidised all at once.

Protein Oxidation and Aggregation

HOCl reacts rapidly with sulfur-containing amino acids — cysteine and methionine — as well as with lysine, histidine and tryptophan residues. The oxidation of cysteine thiol groups to sulfenic, sulfinic and sulfonic acid derivatives disrupts protein tertiary structure. At higher exposures, HOCl causes protein aggregation through cross-linking, effectively gumming up the enzymatic machinery that pathogens need to survive (PMID: 30588272, Del Rosso & Bhatia, J Clin Aesthet Dermatol 2018).

Lipid Peroxidation

Bacterial cell membranes and viral envelopes are rich in unsaturated fatty acids. HOCl initiates lipid peroxidation cascades that compromise membrane integrity, leading to leakage of cytoplasmic contents and, ultimately, cell lysis. This mechanism is particularly relevant for enveloped viruses, where the lipid envelope is essential for infectivity.

DNA and RNA Damage

HOCl reacts with nucleotide bases — particularly pyrimidines — causing chlorination and strand breaks. While this is not the primary killing mechanism for bacteria (protein damage is faster), it contributes to the inactivation of viral genetic material and prevents replication in surviving organisms.

Biofilm Disruption

One of the most clinically significant properties of HOCl is its ability to disrupt biofilms — structured communities of bacteria encased in a self-produced extracellular polymeric substance (EPS) matrix. Biofilms are a major obstacle in chronic wound management because they can be up to 1,000 times more resistant to antibiotics than planktonic (free-floating) bacteria. Sakarya et al. demonstrated that HOCl at concentrations achievable in topical formulations effectively impairs biofilm integrity while simultaneously killing organisms within the biofilm (PMID: 25785777, Wounds 2014). This dual action — killing plus matrix disruption — is rare among topical antiseptics.

Selective Toxicity: Why HOCl Spares Human Cells

This is the question that surprises most people: if HOCl is powerful enough to destroy bacteria in seconds, why does it not destroy the patient’s own tissue? The answer lies in several overlapping protective mechanisms.

The Taurine Chloramine Buffer

Inside the phagosome, HOCl reacts with taurine — a free amino acid present at high concentrations in neutrophils — to form N-chlorotaurine (NCT). NCT is a longer-lived, less reactive oxidant that retains antimicrobial activity but is significantly less damaging to host proteins. This reaction effectively “buffers” the oxidative burst, converting the most aggressive species (HOCl) into a more manageable one (NCT) that still kills pathogens but with a wider therapeutic window (PMID: 37034111, Boecker et al., GMS Hyg Infect Control 2023).

Host Antioxidant Defences

Human cells are equipped with a robust antioxidant infrastructure: catalase, glutathione peroxidase, superoxide dismutase, and high intracellular concentrations of glutathione. These systems can neutralise low-to-moderate concentrations of exogenous HOCl before critical damage accumulates. Bacteria — especially catalase-negative species — lack this redundancy, making them far more vulnerable.

Concentration-Dependent Cytotoxicity

The literature consistently shows that HOCl at concentrations used in wound care formulations (typically 0.01%–0.02%, or roughly 100–200 ppm) is non-cytotoxic to fibroblasts and keratinocytes — the two cell types most critical for wound closure. Sakarya et al. demonstrated dose-dependent favourable effects on fibroblast and keratinocyte migration at these concentrations, meaning HOCl does not merely avoid harming healing tissue; it may actively support the cellular processes that drive wound closure (PMID: 25785777).

By contrast, povidone-iodine (PVP-I) — a commonly used wound antiseptic — has well-documented cytotoxicity to fibroblasts and keratinocytes at standard clinical concentrations. This is one of the key differentiators that has driven the shift toward HOCl in modern wound care protocols.

HOCl and Inflammation: More Than Just a Germ Killer

Emerging research suggests that HOCl’s therapeutic value extends beyond direct antimicrobial action. At the molecular level, HOCl and its secondary chloramines modulate inflammatory signalling pathways in ways that may benefit wound healing.

NF-kB Pathway Modulation

Taurine chloramine (TauCl), the product of HOCl reacting with taurine, has been shown to inhibit NF-kB activation in activated macrophages. NF-kB is a transcription factor that drives the expression of pro-inflammatory cytokines including TNF-alpha, IL-6 and inducible nitric oxide synthase (iNOS). By suppressing NF-kB, TauCl effectively dampens the inflammatory cascade without eliminating it entirely — a nuanced immunomodulatory effect rather than blunt immunosuppression (PMID: 37034111).

Matrix Metalloproteinase (MMP) Regulation

Chronic wounds are characterised by excessive activity of matrix metalloproteinases — enzymes that degrade the extracellular matrix and prevent tissue remodelling. HOCl has been shown to downregulate MMP-7 and collagenase activity at higher concentrations, potentially helping to restore the protease balance necessary for proper wound closure (PMID: 30588272).

Mast Cell Stabilisation

HOCl inhibits mast cell degranulation and histamine release, which may explain its observed benefits in pruritus and inflammatory skin conditions. This is an area of active investigation, but the mechanistic rationale is sound: by stabilising mast cells, HOCl reduces one of the upstream drivers of local inflammation.

HOCl Beyond Wounds: The Nasal Microbiome Connection

The same antimicrobial and anti-inflammatory properties that make HOCl effective in wound care apply to the respiratory mucosa. The nasal cavity is a complex ecosystem hosting a diverse microbiome, and disruptions to this ecosystem are implicated in chronic rhinosinusitis, allergic rhinitis and post-viral olfactory dysfunction.

Research published in 2025 examined HOCl as a respiratory antiseptic, noting its efficacy against common nasal pathogens, its low cytotoxicity to respiratory epithelium, and its ability to modulate local immune responses without the tissue damage associated with alcohol-based or detergent-based nasal products (PMID: 37034111). The nasal application of pH-stabilised HOCl represents a logical extension of the same technology used in wound care — and it is the principle behind Spray8 nasal care.

The respiratory mucosa, like skin, is constantly exposed to environmental pathogens. Delivering a stabilised HOCl solution to this surface provides a topical antimicrobial barrier that works with the body’s own immune mechanisms rather than against them.

Why Formulation Stability Matters

Natural HOCl is unstable. Once produced in the phagosome, it reacts almost immediately with available biomolecules. Creating a shelf-stable HOCl solution that retains its oxidative capacity for months rather than minutes is a genuine engineering challenge.

The key variables are:

• pH. The solution must be maintained in the range where HOCl (not OCl-) dominates — typically pH 5.0–6.5.
• Container chemistry. HOCl reacts with many plastics and metals. High-density polyethylene (HDPE) or specific glass containers are required.
• Light and temperature exposure. UV light and elevated temperatures accelerate decomposition. Opaque, cool storage is essential.
• Ionic purity. Contaminant metal ions catalyse HOCl degradation. Ultra-pure water and high-grade salt are prerequisites for stability.

Products that get these variables right can achieve shelf lives of 12–24 months. Products that do not may lose most of their active HOCl content within weeks. This is not a minor detail — it is the difference between a product that works and a product that is mostly water.

Frequently Asked Questions

Key Takeaways

• HOCl is a naturally occurring antimicrobial produced by neutrophils via the myeloperoxidase system — it is part of your body’s first-line immune defence.
• Its mechanism involves non-specific oxidation of pathogen proteins, lipids and DNA, making resistance development effectively impossible.
• At wound-care concentrations, HOCl is non-cytotoxic to human cells and may actively support fibroblast and keratinocyte migration.
• HOCl disrupts biofilms — a critical advantage in chronic wound management where biofilm-associated infections resist conventional antibiotics.
• Formulation stability is the primary differentiator between effective and ineffective HOCl products; pH, container chemistry and purity all matter.
• The same science applies to nasal care, where HOCl can support a healthy respiratory microbiome without damaging delicate mucosal tissue.